| Pompe & Pain - Study to Assess Nociceptive Pain in Adult Patients With Pompe Disease (NCT05272969) | LMU Klinikum | 2022-03-31 |
| Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells (NCT04975841) | University of Kansas Medical Center | 2022-03-10 |
| Sporadic Inclusion Body Myositis Natural History Study (NCT05046821) | University of California, Irvine | 2021-10-11 |
| A Phase 1 Study of ABC008 in Ascending (Single Ascending Dose/Multiple Ascending Dose) Study in Patients With (IBM) (NCT04659031) | Abcuro, Inc. | 2021-05-25 |
| Safety and Tolerability of Phenylbutyrate in Inclusion Body Myositis (NCT04421677) | University of Kansas Medical Center | 2020-08-20 |
| Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial (NCT04049097) | ZevraDenmark | 2019-05-20 |
| Establishing Muscle Impedance Parameters With Electrical Impedance Myography (NCT03633318) | Yale University | 2018-06-19 |
| Study of Pioglitazone in Sporadic Inclusion Body Myositis (NCT03440034) | Johns Hopkins University | 2018-05-22 |
| Molecular Profile of the Evolution of Inclusion Body Myositis (NCT03299335) | Centre Hospitalier Universitaire de Nice | 2018-02-01 |
| Environmental Risk Factors for Myositis in Military Personnel (NCT01734369) | National Institute of Environmental Health Sciences (NIEHS) | 2014-03-13 |
| Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis (NCT00898989) | Institut de Myologie, France | 2009-04-01 |
| Arimoclomol in Sporadic Inclusion Body Myositis (NCT00769860) | Richard Barohn, MD | 2008-09-01 |
| Lithium in Inclusion Body Myositis (IBM) (NCT00917956) | Phoenix Neurological Associates, LTD | 2008-06-01 |
| Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis (NCT00802815) | Washington University School of Medicine | 2005-04-01 |
| Anakinra in Myositis (NCT01165008) | Karolinska Institutet | 2003-09-01 |
| Adult and Juvenile Myositis (NCT00017914) | National Institute of Environmental Health Sciences (NIEHS) | 1995-06-07 |
| Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies (NCT00001261) | National Institute of Neurological Disorders and Stroke (NINDS) | 1990-05-01 |